Pivot X - Search Results

1

Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE.

Mamounas EP, Untch M, Mano MS, Huang CS, Geyer CE Jr, von Minckwitz G, Wolmark N, Pivot X, Kuemmel S, DiGiovanna MP, Kaufman B, Kunz G, Conlin AK, Alcedo JC, Kuehn T, Wapnir I, Fontana A, Hackmann J, Polikoff J, Saghatchian M, Brufsky A, Yang Y, Zimovjanova M, Boulet T, Liu H, Tesarowski D, Lam LH, Song C, Smitt M, Loibl S. Mamounas EP, et al. Among authors: pivot x. Ann Oncol. 2021 Aug;32(8):1005-1014. doi: 10.1016/j.annonc.2021.04.011. Epub 2021 Apr 28. Ann Oncol. 2021. PMID: 33932503 Free article. Clinical Trial.

2

First-line vinorelbine-mitoxantrone combination in metastatic breast cancer patients relapsing after an adjuvant anthracycline regimen: results of a phase II study.

Llombart-Cussac A, Pivot X, Rhor-Alvarado A, Le Cesne A, Le Chevalier T, Tursz T, Spielmann M. Llombart-Cussac A, et al. Among authors: pivot x. Oncology. 1998 Sep-Oct;55(5):384-90. doi: 10.1159/000011883. Oncology. 1998. PMID: 9732214 Clinical Trial.

3

Result of two randomized trials comparing nolatrexed (Thymitaq) versus methotrexate in patients with recurrent head and neck cancer.

Pivot X, Wadler S, Kelly C, Ruxer R, Tortochaux J, Stern J, Belpomme D, Humblet Y, Domenge C, Clendeninn N, Johnston A, Penning C, Schneider M. Pivot X, et al. Ann Oncol. 2001 Nov;12(11):1595-9. doi: 10.1023/a:1013185402896. Ann Oncol. 2001. PMID: 11822760 Free article. Clinical Trial.

4

Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer.

Pivot X, Awada A, Gedouin D, Kerger J, Rolland F, Cupissol D, Caponigro F, Comella G, Lopez-Pousa JJ, Guardiola E, Giroux B, Gérard B, Schneider M. Pivot X, et al. Ann Oncol. 2003 Mar;14(3):373-7. doi: 10.1093/annonc/mdg114. Ann Oncol. 2003. PMID: 12598340 Free article. Clinical Trial.

5

Phase I and pharmacokinetic study of the association of capecitabine-cisplatin in head and neck cancer patients.

Pivot X, Chamorey E, Guardiola E, Magné N, Thyss A, Otto J, Giroux B, Mouri Z, Schneider M, Milano G. Pivot X, et al. Ann Oncol. 2003 Oct;14(10):1578-86. doi: 10.1093/annonc/mdg410. Ann Oncol. 2003. PMID: 14504061 Free article. Clinical Trial.

6

Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment.

Thomas ES, Gomez HL, Li RK, Chung HC, Fein LE, Chan VF, Jassem J, Pivot XB, Klimovsky JV, de Mendoza FH, Xu B, Campone M, Lerzo GL, Peck RA, Mukhopadhyay P, Vahdat LT, Roché HH. Thomas ES, et al. J Clin Oncol. 2007 Nov 20;25(33):5210-7. doi: 10.1200/JCO.2007.12.6557. Epub 2007 Oct 29. J Clin Oncol. 2007. PMID: 17968020 Clinical Trial.

7

A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients.

Pivot X, Koralewski P, Hidalgo JL, Chan A, Gonçalves A, Schwartsmann G, Assadourian S, Lotz JP. Pivot X, et al. Ann Oncol. 2008 Sep;19(9):1547-52. doi: 10.1093/annonc/mdn171. Epub 2008 Apr 23. Ann Oncol. 2008. PMID: 18436520 Free article. Clinical Trial.

8

Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy.

Bidard FC, Mathiot C, Degeorges A, Etienne-Grimaldi MC, Delva R, Pivot X, Veyret C, Bergougnoux L, de Cremoux P, Milano G, Pierga JY. Bidard FC, et al. Among authors: pivot x. Ann Oncol. 2010 Sep;21(9):1765-1771. doi: 10.1093/annonc/mdq052. Epub 2010 Mar 16. Ann Oncol. 2010. PMID: 20233745 Free article.

9

Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer.

Chan A, Miles DW, Pivot X. Chan A, et al. Among authors: pivot x. Ann Oncol. 2010 Dec;21(12):2305-2315. doi: 10.1093/annonc/mdq122. Epub 2010 Mar 24. Ann Oncol. 2010. PMID: 20335367 Free article. Review.

10

First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients.

Smith IE, Pierga JY, Biganzoli L, Cortés-Funes H, Thomssen C, Pivot X, Fabi A, Xu B, Stroyakovskiy D, Franke FA, Kaufman B, Mainwaring P, Pienkowski T, De Valk B, Kwong A, González-Trujillo JL, Koza I, Petrakova K, Pereira D, Pritchard KI; ATHENA Study Group. Smith IE, et al. Among authors: pivot x. Ann Oncol. 2011 Mar;22(3):595-602. doi: 10.1093/annonc/mdq430. Epub 2010 Sep 5. Ann Oncol. 2011. PMID: 20819780 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

356 results

Search Page